FDA Approves Expanded 26-week Efficacy Claim for Gel-One to Knee OA Pain

Zimmer Biomet announced FDA approval of an expanded 26-week efficacy claim for single-injection Gel-One® Cross-linked Hyaluronate viscosupplement for the treatment of knee pain associated with osteoarthritis.

First US Implant of Vericel’s MACI

Vericel announced the first U.S. implant of MACI® autologous cultured chondrocytes for the treatment of symptomatic knee cartilage defects.

Sirakoss Receives US Patents for Bone Graft Technologies

SIRAKOSS was granted two U.S. patents covering synthetic bone graft technologies, and seeks to raise £3.5MM to £5.0MM in support of U.S. and EU regulatory approvals.